Key Players Mentioned in this Report are:
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global diabetes injection pens market. The report also profiles key players operating in the diabetes injection pens market which are Novo Nordisk A / S, Eli Lilly and Company, AstraZeneca plc, Biocon Ltd., Sanofi S. A., Becton, Dickinson and Company, Owen Mumford Ltd., Jiangsu Delfu Co. and Wockhardt Ltd. The global diabetes injection pens market is dominated by three global vendors that accounts for more than 74 % share of the global market.
The global diabetes injection pens market is segmented as follows:
Global Diabetes Injection Pens Market, by Product Type
� Insulin Pens � Pen Needles
Global Diabetes Injection Pens Market, by Usage
� Reusable Pens � Disposable Pens
Global Diabetes Injection Pens Market, by Distribution Channel
� Hospital Pharmacy � Retail Pharmacy � Online Sales � Diabetes Clinics / Centers